Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
385.10
-5.40 (-1.38%)
Feb 21, 2025, 4:00 PM EST - Market closed
Elevance Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Premiums & Annuity Revenue | 144,166 | 142,854 | 133,229 | 117,373 | 104,109 | Upgrade
|
| Total Interest & Dividend Income | 2,051 | 1,825 | 1,485 | 1,378 | 877 | Upgrade
|
| Other Revenue | 30,593 | 26,661 | 21,885 | 19,892 | 16,882 | Upgrade
|
| Total Revenue | 176,810 | 171,340 | 156,599 | 138,643 | 121,868 | Upgrade
|
| Revenue Growth (YoY) | 3.19% | 9.41% | 12.95% | 13.76% | 16.94% | Upgrade
|
| Policy Benefits | 127,567 | 124,330 | 116,642 | 102,571 | 88,045 | Upgrade
|
| Amortization of Goodwill & Intangibles | 580 | 885 | 767 | 441 | 361 | Upgrade
|
| Selling, General & Administrative | 38,591 | 36,236 | 30,696 | 26,604 | 25,202 | Upgrade
|
| Total Operating Expenses | 166,738 | 161,451 | 148,105 | 129,616 | 113,608 | Upgrade
|
| Operating Income | 10,072 | 9,889 | 8,494 | 9,027 | 8,260 | Upgrade
|
| Interest Expense | -1,185 | -1,030 | -855 | -802 | -785 | Upgrade
|
| EBT Excluding Unusual Items | 8,887 | 8,859 | 7,639 | 8,225 | 7,475 | Upgrade
|
| Merger & Restructuring Charges | -492 | -752 | -39 | -202 | -653 | Upgrade
|
| Gain (Loss) on Sale of Assets | 201 | - | - | - | - | Upgrade
|
| Asset Writedown | - | -392 | - | -7 | - | Upgrade
|
| Legal Settlements | -692 | - | - | - | -548 | Upgrade
|
| Other Unusual Items | - | - | - | -21 | -36 | Upgrade
|
| Pretax Income | 7,904 | 7,715 | 7,600 | 7,995 | 6,238 | Upgrade
|
| Income Tax Expense | 1,933 | 1,724 | 1,712 | 1,846 | 1,666 | Upgrade
|
| Earnings From Continuing Ops. | 5,971 | 5,991 | 5,888 | 6,149 | 4,572 | Upgrade
|
| Net Income to Company | 5,971 | 5,991 | 5,888 | 6,149 | 4,572 | Upgrade
|
| Minority Interest in Earnings | 9 | -4 | 6 | 9 | - | Upgrade
|
| Net Income | 5,980 | 5,987 | 5,894 | 6,158 | 4,572 | Upgrade
|
| Net Income to Common | 5,980 | 5,987 | 5,894 | 6,158 | 4,572 | Upgrade
|
| Net Income Growth | -0.12% | 1.58% | -4.29% | 34.69% | -4.89% | Upgrade
|
| Shares Outstanding (Basic) | 233 | 236 | 240 | 244 | 251 | Upgrade
|
| Shares Outstanding (Diluted) | 233 | 237 | 243 | 247 | 254 | Upgrade
|
| Shares Change (YoY) | -1.90% | -2.22% | -1.62% | -2.95% | -2.31% | Upgrade
|
| EPS (Basic) | 25.68 | 25.38 | 24.56 | 25.26 | 18.23 | Upgrade
|
| EPS (Diluted) | 25.68 | 25.22 | 24.28 | 24.95 | 17.98 | Upgrade
|
| EPS Growth | 1.81% | 3.87% | -2.69% | 38.77% | -2.65% | Upgrade
|
| Free Cash Flow | 4,552 | 6,765 | 7,247 | 7,277 | 9,667 | Upgrade
|
| Free Cash Flow Per Share | 19.54 | 28.50 | 29.85 | 29.49 | 38.01 | Upgrade
|
| Dividend Per Share | 6.520 | 5.920 | 5.120 | 4.520 | 3.800 | Upgrade
|
| Dividend Growth | 10.14% | 15.63% | 13.27% | 18.95% | 18.75% | Upgrade
|
| Operating Margin | 5.70% | 5.77% | 5.42% | 6.51% | 6.78% | Upgrade
|
| Profit Margin | 3.38% | 3.49% | 3.76% | 4.44% | 3.75% | Upgrade
|
| Free Cash Flow Margin | 2.57% | 3.95% | 4.63% | 5.25% | 7.93% | Upgrade
|
| EBITDA | 11,465 | 10,949 | 9,570 | 9,844 | 9,002 | Upgrade
|
| EBITDA Margin | 6.48% | 6.39% | 6.11% | 7.10% | 7.39% | Upgrade
|
| D&A For EBITDA | 1,393 | 1,060 | 1,076 | 817 | 742 | Upgrade
|
| EBIT | 10,072 | 9,889 | 8,494 | 9,027 | 8,260 | Upgrade
|
| EBIT Margin | 5.70% | 5.77% | 5.42% | 6.51% | 6.78% | Upgrade
|
| Effective Tax Rate | 24.46% | 22.35% | 22.53% | 23.09% | 26.71% | Upgrade
|
| Revenue as Reported | 177,011 | 171,340 | 156,595 | 138,639 | 121,867 | Upgrade
|
Source: S&P Capital IQ. Insurance template. Financial Sources.